Key Highlights

  • Acadia Healthcare (NASDAQ:ACHC) traded at USD 36.26 on the snapshot date after a 12.43% jump in the latest session, and has climbed 21.51% over one week and 25.75% over one month.
  • Third quarter Revenue reached USD 895.3 million, up 5.1% from USD 851.6 million, with same-facility revenue up 5.2% and adjusted EBITDA of USD 176.4 million against USD 173.0 million.
  • Diluted EPS slipped to USD 0.38 from USD 0.40 and adjusted EPS to USD 0.60 from USD 0.72, yet 2026 adjusted EPS guidance moved up to USD 1.70 to USD 1.80 from USD 1.45 to USD 1.60.
  • Adjusted EBITDA guidance now sits at USD 615 million to USD 625 million, up from USD 590 million to USD 615 million, and net Leverage stands at 3.9x.

Third Quarter Revenue Growth Offsets Softer Per-Share Profit

Acadia Healthcare released third quarter 2026 results at 4:05 p.m. ET on November 4, 2026, and the stock rose 12.43% in the following session to USD 36.26. Revenue grew 5.1% to USD 895.3 million, while same-facility revenue advanced 5.2%. Net Income attributable to the company eased to USD 34.5 million from USD 36.2 million, though adjusted net income reached USD 54.6 million. Operating Cash Flow was USD 97.9 million after USD 50.7 million of capital expenditures, which suggests the outlook change did most of the work in the share reaction.

Raised 2026 Targets Lift Revenue, EBITDA and Cash Flow Estimates

The 2026 outlook was lifted on several lines. Full year revenue is now guided to USD 3.44 billion to USD 3.46 billion, up from USD 3.40 billion to USD 3.45 billion, and operating cash flow to USD 375 million to USD 400 million. Capital Expenditure guidance was trimmed to USD 210 million to USD 230 million from USD 235 million to USD 255 million. When a leveraged operator raises its outlook, both Earnings estimates and the valuation multiple can move, and short covering can amplify the gain. Because net leverage stands at 3.9x, the revised EBITDA range carries extra weight for the balance sheet.

Debt Load, Share Count Context and Risks After a 47.34% Six Month Run

The shares rose 19.75% over three months and 47.34% over six months, though year to date performance was not visible. An earlier published market data snapshot listed a USD 29.62 price, a Market Value of USD 2.76 billion and a float of 91.63 million shares; at USD 36.26 the value is higher and still sits in the Mid cap range. Long-term Debt was USD 2,319.9 million plus a USD 32.5 million current portion, while cash stood at USD 163.3 million and USD 710.1 million of the USD 1.0 billion revolver was available. Adjusted EPS of USD 0.60 fell from USD 0.72. A 12.43% one-day jump can partly reverse, a small number of trades can move the price, and spreads can be wide. Average Volume and the 52-week range were not available.

Where Things Stand

Acadia Healthcare (NASDAQ:ACHC) jumped because third quarter revenue rose 5.1% and management lifted 2026 targets for revenue, EBITDA and adjusted EPS. The 21.51% weekly gain ranks among the stronger mid cap moves of the latest week, with a 25.75% one month rise behind it. Lower diluted and adjusted EPS year over year, plus net leverage of 3.9x, temper the picture. This is market context, not a forecast or a recommendation.